ABOUT US

Introduction
Chairman's Statement
Contact Us
R&D

R&D Platforms
R&D Capability
R&D Center
Scientific Activities
PRODUCTS

bFGF Series
other ophthalmic products
other surgical products
NEWS

company news
investee news
media focus
INVESTOR RELATIONS

Announcements & Shareholder Info
Corporate Info
Financial & ESG Reports
Contact Us
CAREERS

Talent Concept
Job Opportunities
简 繁 EN
Essex-Bio Group
简 繁 EN
简 繁 EN
INVESTEE NEWS
MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency
2019.05.14 Download
Related news
AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer™, an Investigational Treatment for Alzheimer’s Disease
2019-07-22
MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency
2019-05-14
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies
2019-02-28
Essex-Bio Group
BIOTECH
HEALTHTECH
Links
Mitotech S.A.
Antikor Biopharma
Humacyte
Shang Gong
Contact us
Copyright © 2020 Essex Bio-Technology Limited All Rights Reserved.
Disclaimer | Privacy Policy
Guangdong ICP NO.09032349-1 深圳网站建设 深圳联雅
This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.
ACCEPT